Jefferson University Hospitals

Provider Profile

Walter Kraft, MD

Jefferson University Physician

Academic Title: Professor
Director, Clinical Research Unit and Division of Clinical Pharmacology

Specialties
Clinical Pharmacology (Not Accepting New Patients)
Vascular Medicine (Not Accepting New Patients)

Office Locations

Philadelphia
Gibbon Bldg., Ste. 6270
111 S. 11th Street
Philadelphia PA 19107
Phone: (215) 955-6540
Fax: (215) 923-0835

Medical Services

Years in Practice

17

Board Certifications

  • Internal Medicine
  • Clinical Pharmacology

Hospital Affiliation / Admitting Privileges

  • Thomas Jefferson University Hospital

Awards and Honors

United States Pharmacopeia, Medical School Representative

Governing Board Member, American Board of Clinical Pharmacology 2010,2009,2008,2007

Top 25 Most Highly Rated Teachers, Thomas Jefferson University Hospital Internal Medicine Residency 2008

Jefferson Medical College Early Career Investigator Award for Distinguished Achievement in Biomedical Research 2010

Treasurer, American Society for Clinical Pharmacology and Therapeutics 2018,2016,2017

Education

  • University of Pittsburgh, Medical School

Internship

  • Thomas Jefferson University Hospital

Residency

  • Thomas Jefferson University Hospital

Fellowship

  • Thomas Jefferson University Hospital

Recent Publications

Fasoracetam in adolescents with ADHD and glutamatergic gene network variants disrupting mGluR neurotransmitter signaling

Buprenorphine in Neonatal Abstinence Syndrome

The Impact of a Transition of Care Program on Acute Myocardial Infarction Readmission Rates

Medication Complications in Extracorporeal Membrane Oxygenation

The authors reply

The Nephrotoxicity of Vancomycin

Tumor necrosis factor inhibitors in psoriatic arthritis

Buprenorphine for the treatment of the neonatal abstinence syndrome

Bioactivity of oral linaclotide in human colorectum for cancer chemoprevention

A population pharmacokinetic model for vancomycin in adult patients receiving extracorporeal membrane oxygenation therapy

Beta-blocker therapy and impact on outcome after aneurysmal subarachnoid hemorrhage: A cohort study

Effect of Vorapaxar Alone and in Combination with Aspirin on Bleeding Time and Platelet Aggregation in Healthy Adult Subjects

Reversibility of Apixaban Anticoagulation with a Four-Factor Prothrombin Complex Concentrate in Healthy Volunteers

Neonatal abstinence syndrome: Pharmacologic strategies for the mother and infant

A Two-Step Haploidentical Versus a Two-Step Matched Related Allogeneic Myeloablative Peripheral Blood Stem Cell Transplantation

Population Pharmacokinetic Model of Sublingual Buprenorphine in Neonatal Abstinence Syndrome

Pharmacologic and clinical evaluation of posaconazole

Ethanol Pharmacokinetics in Neonates and Infants

Current Therapeutic Research is Now Indexed on PubMed

Posaconazole tablet pharmacokinetics: Lack of effect of concomitant medications altering gastric pH and gastric motility in healthy subjects